Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Arthritis Research & Therapy
Published in: Arthritis Research & Therapy 4/2008

Open Access 01-08-2008 | Research article

Biochemical markers of bone turnover and their association with bone marrow lesions

Authors: David J Hunter, Michael LaValley, Jiang Li, Doug C Bauer, Michael Nevitt, Jeroen DeGroot, Robin Poole, David Eyre, Ali Guermazi, Daniel Gale, Saara Totterman, David T Felson

Published in: Arthritis Research & Therapy | Issue 4/2008

Login to get access

Abstract

Introduction

Our objective was to determine whether markers of bone resorption and formation could serve as markers for the presence of bone marrow lesions (BMLs).

Methods

We conducted an analysis of data from the Boston Osteoarthritis of the Knee Study (BOKS). Knee magnetic resonance images were scored for BMLs using a semiquantitative grading scheme. In addition, a subset of persons with BMLs underwent quantitative volume measurement of their BML, using a proprietary software method. Within the BOKS population, 80 people with BMLs and 80 without BMLs were selected for the purposes of this case-control study. Bone biomarkers assayed included type I collagen N-telopeptide (NTx) corrected for urinary creatinine, bone-specific alkaline phosphatase, and osteocalcin. The same methods were used and applied to a nested case-control sample from the Framingham study, in which BMD assessments allowed evaluation of this as a covariate. Logistic regression models were fit using BML as the outcome and biomarkers, age, sex, and body mass index as predictors. An receiver operating characteristic curve was generated for each model and the area under the curve assessed.

Results

A total of 151 subjects from BOKS with knee OA were assessed. The mean (standard deviation) age was 67 (9) years and 60% were male. Sixty-nine per cent had maximum BML score above 0, and 48% had maximum BML score above 1. The only model that reached statistical significance used maximum score of BML above 0 as the outcome. Ln-NTx (Ln is the natural log) exhibited a significant association with BMLs, with the odds of a BML being present increasing by 1.4-fold (95% confidence interval = 1.0-fold to 2.0-fold) per 1 standard deviation increase in the LnNTx, and with a small partial R2 of 3.05. We also evaluated 144 participants in the Framingham Osteoarthritis Study, whose mean age was 68 years and body mass index was 29 kg/m2, and of whom 40% were male. Of these participants 55% had a maximum BML score above 0. The relationship between NTx and maximum score of BML above 0 revealed a significant association, with an odds ratio fo 1.7 (95% confidence interval = 1.1 to 2.7) after adjusting for age, sex, and body mass index.

Conclusions

Serum NTx was weakly associated with the presence of BMLs in both study samples. This relationship was not strong and we would not advocate the use of NTx as a marker of the presence of BMLs.
Literature
1.
Burr DB: The importance of subchondral bone in the progression of osteoarthritis. J Rheumatol Suppl. 2004, 70: 77-80.PubMed
2.
Patel V, Issever AS, Burghardt A, Laib A, Ries M, Majumdar S: MicroCT evaluation of normal and osteoarthritic bone structure in human knee specimens. J Orthopaedic Res. 2003, 21: 6-13. 10.1016/S0736-0266(02)00093-1.CrossRef
3.
Burr DB: The importance of subchondral bone in osteoarthrosis. Curr Opin Rheumatol. 1998, 10: 256-262. 10.1097/00002281-199805000-00017.CrossRefPubMed
4.
Felson DT, Chaisson CE, Hill CL, Totterman SM, Gale ME, Skinner KM, Kazis L, Gale DR: The association of bone marrow lesions with pain in knee osteoarthritis. Ann Intern Med. 2001, 134: 541-549.CrossRefPubMed
5.
Speer KP, Spritzer CE, Bassett FH, Feagin JA, Garrett WE: Osseous injury associated with acute tears of the anterior cruciate ligament. Am J Sports Med. 1992, 20: 382-389. 10.1177/036354659202000403.CrossRefPubMed
6.
McAlindon TE, Watt I, McCrae F, Goddard P, Dieppe PA: Magnetic resonance imaging in osteoarthritis of the knee: correlation with radiographic and scintigraphic findings. Ann Rheum Dis. 1991, 50: 14-19. 10.1136/ard.50.1.14.PubMedCentralCrossRefPubMed
7.
Dieppe P, Cushnaghan J, Young P, Kirwan J: Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy. Ann Rheum Dis. 1993, 52: 557-563. 10.1136/ard.52.8.557.PubMedCentralCrossRefPubMed
8.
Boegard T, Rudling O, Dahlstrom J, Dirksen H, Petersson IF, Jonsson K: Bone scintigraphy in chronic knee pain: comparison with magnetic resonance imaging. Ann Rheum Dis. 1999, 58: 20-26.PubMedCentralCrossRefPubMed
9.
Felson DT, McLaughlin S, Goggins J, LaValley M, Gale M, Totterman S, Li W, Hill C, Gale D: Bone marrow edema and its relation to X-ray progression in knee osteoarthritis. Ann Intern Med. 2003, 139: 330-336.CrossRefPubMed
10.
Zanetti M, Bruder E, Romero J, Hodler J: Bone marrow edema pattern in osteoarthritic knees: correlation between MR imaging and histologic findings. Radiology. 2000, 215: 835-840.CrossRefPubMed
11.
12.
Mansell JP, Tarlton JF, Bailey AJ: Biochemical evidence for altered subchondral bone collagen metabolism in osteoarthritis of the hip. Br J Rheumatol. 1997, 36: 16-19. 10.1093/rheumatology/36.1.16.CrossRefPubMed
13.
Karvonen RL, Miller PR, Nelson DA, Granda JL, Fernandez-Madrid F: Periarticular osteoporosis in osteoarthritis of the knee. J Rheumatol. 1998, 25: 2187-2194.PubMed
14.
Li B, Aspden RM: Material properties of bone from the femoral neck and calcar femorale of patients with osteoporosis or osteoarthritis. Osteoporos Int. 1997, 7: 450-456. 10.1007/s001980050032.CrossRefPubMed
15.
Grynpas MD, Alpert B, Katz I, Lieberman I, Pritzker KP: Subchondral bone in osteoarthritis. Calcif Tissue Int. 1991, 49: 20-26. 10.1007/BF02555898.CrossRefPubMed
16.
Hunter DJ, Spector TD: The role of bone metabolism in osteoarthritis. Curr Rheumatol Rep. 2003, 5: 15-19. 10.1007/s11926-003-0078-5.CrossRefPubMed
17.
Bettica P, Cline G, Hart D, Meyer J, Spector T: Evidence for increased bone resorption in patients with progressive knee OA: longitudinal results from the Chingford study. Arthritis Rheum. 2002, 46: 3178-3184. 10.1002/art.10630.CrossRefPubMed
18.
Hunter DJ, Hart D, Snieder H, Bettica P, Swaminathan R, Spector TD: Evidence of altered bone turnover, vitamin D and calcium regulation with knee osteoarthritis in female twins. Rheumatology. 2003, 42: 1311-1316. 10.1093/rheumatology/keg373.CrossRefPubMed
19.
Dequeker J, Mohan S, Finkelman RD, Aerssens J, Baylink DJ: Generalized osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor beta in cortical bone from the iliac crest. Possible mechanism of increased bone density and protection against osteoporosis. Arthritis Rheum. 1993, 36: 1702-1708. 10.1002/art.1780361209.CrossRefPubMed
20.
Hart DJ, Cronin C, Daniels M, Worthy T, Doyle DV, Spector TD: The relationship of bone density and fracture to incident and progressive radiographic osteoarthritis of the knee: the Chingford Study. Arthritis Rheum. 2002, 46: 92-99. 10.1002/1529-0131(200201)46:1<92::AID-ART10057>3.0.CO;2-#.CrossRefPubMed
21.
Zhang Y, Hannan MT, Chaisson CE, McAlindon TE, Evans SR, Aliabadi P, Levy D, Felson DT: Bone mineral density and risk of incident and progressive radiographic knee osteoarthritis in women: the Framingham Study. J Rheumatol. 2000, 27: 1032-1037.PubMed
22.
Felson DT, McLaughlin S, Goggins J, LaValley MP, Gale ME, Totterman S, Li W, Hill C, Gale D: Bone marrow edema and its relation to progression of knee osteoarthritis. Ann Intern Med. 2003, 139: 330-336.CrossRefPubMed
23.
Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M: Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986, 29: 1039-1049. 10.1002/art.1780290816.CrossRefPubMed
24.
Chaisson CE, Gale DR, Gale E, Kazis L, Skinner K, Felson DT: Detecting radiographic knee osteoarthritis: what combination of views is optimal?. Rheumatology. 2000, 39: 1218-1221. 10.1093/rheumatology/39.11.1218.CrossRefPubMed
25.
Felson DT, Naimark A, Anderson J, Kazis L, Castelli W, Meenan RF: The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum. 1987, 30: 914-918. 10.1002/art.1780300811.CrossRefPubMed
26.
Karlson EW, Sanchez-Guerrero J, Wright EA, Lew RA, Daltroy LH, Katz J, Liang MH: A connective tissue disease screening questionnaire for population studies. Ann Epidemiol. 1995, 5: 297-302. 10.1016/1047-2797(94)00096-C.CrossRefPubMed
27.
Lo GH, Hunter DJ, Zhang Y, McLennan CE, LaValley MP, Kiel DP, McLean RR, Genant HK, Guermazi A, Felson DT: Bone marrow lesions in the knee are associated with increased local bone density. Arthritis Rheum. 2005, 52: 2814-2821. 10.1002/art.21290.CrossRefPubMed
28.
Peterfy CG, Guermazi A, Zaim S, Tirman PF, Miaux Y, White D, Kothari M, Lu Y, Fye K, Zhao S, Genant HK: Whole-Organ Magnetic Resonance Imaging Score (WORMS) of the knee in osteoarthritis. Osteoarthritis Cartilage. 2004, 12: 177-190. 10.1016/j.joca.2003.11.003.CrossRefPubMed
29.
Gomez BJ, Ardakani S, Ju J, Jenkins D, Cerelli MJ, Daniloff G, Kung VT: Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum. Clin Chem. 1995, 41: 1560-1566.PubMed
30.
Garnero P, Grimaux M, Seguin P, Delmas PD: Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro. J Bone Miner Res. 1994, 9: 255-264.CrossRefPubMed
31.
Rosenquist C, Qvist P, Bjarnason N, Christiansen C: Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies. Clin Chem. 1995, 41: 1439-1445.PubMed
32.
Ju HS, Leung S, Brown B, Stringer MA, Leigh S, Scherrer C, Shepard K, Jenkins D, Knudsen J, Cannon R: Comparison of analytical performance and biological variability of three bone resorption assays. Clin Chem. 1997, 43: 1570-1576.PubMed
33.
Bettica P, Cline G, Hart DJ, Meyer J, Spector TD: Evidence for increased bone resorption in patients with progressive knee osteoarthritis: longitudinal results from the Chingford study. Arthritis Rheumatism. 2002, 46: 3178-3184. 10.1002/art.10630.CrossRefPubMed
34.
Stewart A, Black A, Robins SP, Reid DM: Bone density and bone turnover in patients with osteoarthritis and osteoporosis. J Rheumatol. 1999, 26: 622-626.PubMed
35.
Garnero P, Piperno M, Gineyts E, Christgau S, Delmas PD, Vignon E: Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis. 2001, 60: 619-626. 10.1136/ard.60.6.619.PubMedCentralCrossRefPubMed
36.
Garnero P, Peterfy C, Zaim S, Schoenharting M: Bone marrow abnormalities on magnetic resonance imaging are associated with type II collagen degradation in knee osteoarthritis: a three-month longitudinal study. Arthritis Rheum. 2005, 52: 2822-2829. 10.1002/art.21366.CrossRefPubMed
37.
Garnero P, Ayral X, Rousseau JC, Christgau S, Sandell LJ, Dougados M, Delmas PD: Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthritis Rheum. 2002, 46: 2613-2624. 10.1002/art.10576.CrossRefPubMed
38.
Bruyere O, Collette JH, Ethgen O, Rovati LC, Giacovelli G, Henrotin YE, Seidel L, Reginster JY: Biochemical markers of bone and cartilage remodeling in prediction of longterm progression of knee osteoarthritis. J Rheumatol. 2003, 30: 1043-1050.PubMed
39.
Sowers M, Lachance L, Jamadar D, Hochberg MC, Hollis B, Crutchfield M, Jannausch ML: The associations of bone mineral density and bone turnover markers with osteoarthritis of the hand and knee in pre- and perimenopausal women. Arthritis Rheum. 1999, 42: 483-489. 10.1002/1529-0131(199904)42:3<483::AID-ANR13>3.0.CO;2-O.CrossRefPubMed
40.
Rosen HN, Dresner-Pollak R, Moses AC, Rosenblatt M, Zeind AJ, Clemens JD, Greenspan SL: Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover. Calcif Tissue Int. 1994, 54: 26-29. 10.1007/BF00316285.CrossRefPubMed
41.
Poole AR, Witter J, Roberts N, Piccolo F, Brandt R, Paquin J, Baron M: Inflammation and cartilage metabolism in rheumatoid arthritis. Studies of the blood markers hyaluronic acid, orosomucoid, and keratan sulfate. Arthritis Rheum. 1990, 33: 790-799. 10.1002/art.1780330605.CrossRefPubMed
42.
Hunter DJ, Li J, LaValley M, Bauer DC, Nevitt M, DeGroot J, Poole R, Eyre D, Guermazi A, Gale D, Felson DT: Cartilage markers and their association with cartilage loss on magnetic resonance imaging in knee osteoarthritis: the Boston Osteoarthritis Knee Study. Arthritis Res Ther. 2007, 9: R108-10.1186/ar2314.PubMedCentralCrossRefPubMed
Metadata
Title
Biochemical markers of bone turnover and their association with bone marrow lesions
Authors
David J Hunter
Michael LaValley
Jiang Li
Doug C Bauer
Michael Nevitt
Jeroen DeGroot
Robin Poole
David Eyre
Ali Guermazi
Daniel Gale
Saara Totterman
David T Felson
Publication date
01-08-2008
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 4/2008
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar2494

Other articles of this Issue 4/2008

Arthritis Research & Therapy 4/2008 Go to the issue

Research article

Presence and utility of IgA-class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis: the Swedish TIRA project

Editorial

Altered fractalkine cleavage results in an organ-specific 17 kDa fractalkine fragment in salivary glands of NOD mice

Research article

Local adherent technique for transplanting mesenchymal stem cells as a potential treatment of cartilage defect

Research article

A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin®for treatment of osteoarthritis of the knee

Research article

Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis

Research article

A meta-analysis of the efficacy of fibromyalgia treatment according to level of care
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits